Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
APTA 2022 CSM: Calling All ‘Pandemic Whisperers’ To Address Ethical Challenges

Feb 4, 2022/Article

The 53rd McMillan Lecture focused on ways the pandemic has highlighted the need to fully integrate ethics into the profession's identity.

Coronavirus Update: March 24

Mar 24, 2021/Roundup

Vaccine practice advisory, outcomes for MS patients, long COVID-19 news, and more.

APTA Chapters Fuel State-Level Wins

Jul 24, 2023/Roundup

Growing participation in the PT Compact, expanded direct access, ability to order imaging, limits on prior authorization, and more.

2022 FPTR Scholarship, Fellowship Awards Announced

Jul 11, 2022/News

Supported in part by APTA and its academies, the awards are an investment in promising physical therapy investigators.

Long COVID

Sep 23, 2022/Clinical Summary

Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. As of July 19, 2022, over 559 million cases of COVID-19 and 6.3 million deaths have been confirmed.

APTA State Chapters Fuel Legislative Wins in 2025

Aug 6, 2025/News

As the 2025 legislative season has come to a close in most states, many APTA chapters achieved significant victories that improve payment, address provider credentialing, and reduce administrative burden.

Roger Herr, PT, MPA

Mar 3, 2022/Author

Roger Herr, PT, MPA, is APTA President for a three-year term of 2021 through 2023.

2021 Foundation Scholarship Awards Fuel Wide Range of Research Areas

Jul 6, 2021/News

Supported in part by APTA and its academies, the awards are an investment in promising physical therapy investigators.

From PTJ: Finding the Right Combination for Treatment of Cervicogenic Headache

Jan 31, 2024/Review

Researchers see promise in multiple combinations, including spinal joint manipulation and dry needling.

Study: Pre- and Post-TKR Physical Therapy Lowers Odds of Long-Term Opioid Use

Nov 5, 2021/Review

A large-scale study found that the lowered odds are especially significant for "opioid-experienced" patients.